Other conferences by IBC »
You are here: Home » About The Conference
About The Conference

Event Overview

Exploring China’s Contribution to Global R&D
The purpose of this event is to bring together leaders from across East and West, pharma and biotech, discovery and clinical to discuss the future of innovation and map the growth potential for the industry in Asia as well as Asia’s contribution to global R&D.

China Pharmaceutical R&D Summit forms part of IBC’s Drug Discovery and Development week. Reputed for bringing together 300+ international thought-leaders, this is your opportunity to meet like-minded Executives to discuss developments and collaborations in pharma R&D.

What’s Different About IBC’s China R&D Summit?

  • Quality content and scientific exchange
  • Industry researched programme
  • Industry driven presentations
  • High-level domestic speakers and perspectives from China-based companies
  • Key insights on the political, regulatory and legal environment in China
  • Targeted audience enabling meaningful networking and interactions with speakers and participants
The 2013 Programme Features:
  • A fresh speaker panel and new case studies, including ‘of the moment’ collaborations such as Ironwood-AstraZeneca and NeuroVive-Sihuan
  • Key established and emerging domestic companies such as Chipscreen,  SK Biopharma, Genor, Hua Medicine and Shanghai Genomics
  • Insights from leading investment experts including OrbiMed, FIL Capital Management, Sequoia Capital, KPCB and Goldman Sachs
  • New interactive formats including Pharma Fireside Chat, CxO Panel Discussion, and Industry Strategizing Session

See complete agenda

Previous Attending Companies Include:

  • GlaxoSmithKline China Investment Co Ltd
  • SK Bio-Pharm Tech (Shanghai) Co Ltd
  • Pfizer Investment Co Ltd
  • National Health Research Institutes
  • Celgene Pte Ltd
  • Ricerca Taiwan Ltd
  • Abbott Laboratories
  • Sanofi (China) Investment Co Ltd
  • Kirin Kunpeng (China) Bio-Pharmaceutical Co Ltd
  • Guangzhou International Biotech Island Investment & Development Co Ltd
  • Rong Gang Life Technology Beijing Co.Ltd
  • Suzhou Joekai Biotechnology L L C
  • Wincon Theracells Biotechnologies Co Ltd
  • Takeda Global Research & Development Center (Asia) Pte Ltd
  • Sunovion Pharmaceuticals Inc
  • Kyowa Hakko Kirin Co., Ltd
  • Bayer Healthcare Co Ltd
  • Medipolis Medical Research Institute
  • Binocular Vision
  • DNS-China
  • Eisai Clinical Research Singapore Pte Ltd
 Register Now
Register Online
+65 6508 2401
+65 6508 2407
Customer Services

Download Prospectus

 Co-located With:

Download New Emerging R&D and Clinical Trial Locations White Paper
  Post Event Report

 Quick Links

 Connect Now
Add to Calendar
Add to Favourites
Register for E-update

Produced By
Panel Sponsors  
Bronze Sponsor


Supported by

Media Partners